The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Chondromel 400 mg Capsules



IBSA Farmaceutici Italia S.r.lPA1104/003/001

Main Information

Trade NameChondromel 400 mg Capsules
Active SubstancesChondroitin sulfate
Dosage FormCapsule, hard
Licence HolderIBSA Farmaceutici Italia S.r.l
Licence NumberPA1104/003/001

Group Information

ATC CodeM01 ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS

Status

License statusAuthorised
Licence Issued22/12/2005
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back